| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |